Breast Cancer
Conference Coverage
SABCS 2017: Top picks from Dr. Hope S. Rugo
Anticipated presentations include updates on I-SPY2 and the TEXT and SOFT trials, as well as an evaluation of predicting late recurrences using...
Case-Based Review
Genomic Testing in Women with Early-Stage Hormone Receptor–Positive, HER2-Negative Breast Cancer
Over the past several decades, while the incidence of breast cancer has increased, breast cancer mortality has decreased. This decrease is likely...
Conference Coverage
SABCS opening plenary to address potential of RT to transform tumors into vaccines
Dr. Silvia Formenti of Weill Cornell Medicine will outline her ongoing clinical work to combine RT with immune checkpoint inhibitors to evoke T-...
Conference Coverage
Cancer patients with TKI-induced hypothyroidism had better survival rates
When it comes to the adverse effects of tyrosine kinase inhibitors, hypothyroidism appears to have a bright side.
Conference Coverage
NCI-MATCH: Nivolumab shows promising activity in noncolorectal cancers
Nivolumab has promising activity in mismatch repair–deficient noncolorectal cancers, according to preliminary findings from the NCI-MATCH trial....
Latest News
The better mammogram: Experts explore sensitivity of new modalities
PHILADELPHIA – Newer technologies such as tomosynthesis and molecular breast imaging could be especially helpful in screening women with dense...
From the Journals
Frailty, not age, predicted complications after ambulatory surgery
Frailty was associated with a significant increase in 30-day complications after ambulatory hernia repair.
Conference Coverage
Breast cancer margin guidelines reduced re-excisions, cost
SCOTTSDALE, ARIZ. – Costs and re-excisions for invasive breast cancer were reduced after the implementation of the “no tumor on ink” in a single-...
From the Journals
Breast cancer recurrence risk substantial after endocrine treatment
Women who stop adjuvant endocrine therapy after 5 years are still at substantial risk of distant recurrence over the next 15 years, even if their...
From the Journals
New persistent opioid use common after cancer surgery
One year after surgery, patients who developed new persistent opioid use were still filling prescriptions at high daily opioid doses, equivalent...
News from the FDA/CDC
Reconstruction becoming more common after mastectomy
Nonsimultaneous procedure has gained popularity and moved out of the hospital.